Athenex is a biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer. The company operates in three segments, including its Oncology Innovation Platform, dedicated to the research and development of the company's proprietary drugs; its Commercial Platform, focused on the sales and marketing of the company's specialty drugs and the market development of its proprietary drugs; and its Global Supply Chain Platform, dedicated to providing a stable supply of active pharmaceutical ingredients for its clinical and commercial efforts. The company's clinical pipeline includes: Orascovery, Src kinase inhibition, T-cell receptor-engineered T-cells, and Arginine deprivation therapy.
  • TickerATNX
  • ISINUS04685N1037
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States
Dave Nicoski ...
  • Ross LaDuke

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

Dave Nicoski ...
  • Ross LaDuke

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

Jonathan Moreland

InsiderInsights Weekly Tables: March 28, 2020

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Athenex Inc: 1 director bought

A director at Athenex Inc bought 50,000 shares at 7.250USD and the significance rating of the trade was 58/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board m...

MarketLine Department

Empire Industries Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances And Investments

Summary Marketline's Empire Industries Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Empire Industries Ltd. since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive adva...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch